CRL 241220 115.00P (CRL241220P115000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

CRL241220P115000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 11 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Kevin TraversDec 11 10:47 ET
Market Falls Wednesday, but Googles Chip Impresses | WST
Kevin TraversDec 10 16:19 ET
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Kevin TraversDec 10 10:51 ET
Here's Why Charles River Associates Stock Is a Great Pick
Zacks Dec 10 05:30 ET
The USA healthcare system has long been in collapse! Industry executives: The CEO shooting incident has sounded the alarm for the industry.
① Mark Bertolini, CEO of Oscar Health, believes that the USA healthcare system is considered outdated and ineffective, which has led to a lack of sympathy from the public towards the assassination of Company Executives in the healthcare sector. ② The stock prices in the USA healthcare Industry have already been significantly affected by the shooting incident, and Analyst Jared Holz from Mizuho expects that subsequent uncertainties will continue.
cls.cnDec 10 05:26 ET
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock
Kevin TraversDec 9 11:19 ET

Comments

Moomoo AI

Feb 29 01:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26 04:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.

Have Charles River Laboratories International Insiders Been Selling Stock?

Moomoo AI

Feb 16 09:18

EPS growth outshines the yearly share price gain of 12%, indicating market caution towards the stock. Despite sell-off, long term shareholders gained 12% annually over five years, suggesting the sell-off might be a growth opportunity.

Charles River Laboratories International (NYSE:CRL) Stock Performs Better Than Its Underlying Earnings Growth Over Last Five Years

Moomoo AI

Jan 17 06:06

Charles River Laboratories International's high P/E ratio is concerning due to its lower than expected growth. Investors seem more bullish than analysts, but current prices may not be sustainable without significant improvement.

Getting In Cheap On Charles River Laboratories International, Inc. (NYSE:CRL) Is Unlikely

Moomoo AI

Nov 17, 2023 04:30

The recent and long-term insider transactions demonstrate a positive outlook about the company. The significant insider ownership of the company also indicates well-aligned incentives between the management and shareholders. Charles River Laboratories International may potentially be a promising investment.

James Foster Bought 2.3% More Shares In Charles River Laboratories International